Argos Therapeutics, Inc. Share Price - ARGS

Best deals to access real time data!
USA ULTIMATE TRADER
Monthly Subscription
for only
US$72.99
USA SMALL CAP PRO
Monthly Subscription
for only
US$44.59
DDE w/Realtime USA (Monthly)
Monthly Subscription
for only
US$31.00
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Argos Therapeutics, Inc. ARGS Other OTC Common Stock
  Price Change Price Change % Stock Price High Price Low Price Open Price Close Price Last Trade
  -0.0084 -5.14% 0.1551 0.1713 0.1511 0.1511 0.1635 02:37:57
Bid Price Ask Price Spread Spread % News
0.155 0.1748 0.0198 11.33% - -
Trades Stocks Traded VWAP Financial Volume Average Volume 52 Week Range
21 6,336 US$ 0.1614 US$ 1.02k 113.19k 0.14 - 0.30
Last Trade Type Quantity Price Currency
02:21:48 1 US$0.16 USD

Argos Therapeutics, Inc. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.64M 10.59M $ -40.58M - -0.04 6.78M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Argos Therapeutics, Inc. News

Date Time Source News Article
16/5/201807:06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)
16/5/201806:52Edgar (US Regulatory)Quarterly Report (10-q)
10/5/201802:32Edgar (US Regulatory)Confidential Treatment Order (ct Order)
25/4/201807:31Edgar (US Regulatory)Current Report Filing (8-k)
19/4/201822:06Edgar (US Regulatory)Current Report Filing (8-k)
19/4/201822:00GlobeNewswire Inc.Argos Therapeutics Reports Results of Interim Analysis of..
03/4/201807:09Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)

Historical ARGS Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Month0.167550.190.13750.16305k191k36k-0.01245-7.43%
3 Months0.220.30250.13750.21345k2M113k-0.0649-29.50%
6 Months0.220.30250.13750.21345k2M113k-0.0649-29.50%
1 Year0.220.30250.13750.21345k2M113k-0.0649-29.50%
3 Years0.220.30250.13750.21345k2M113k-0.0649-29.50%
5 Years0.220.30250.13750.21345k2M113k-0.0649-29.50%

Argos Therapeutics, Inc. Description

Argos Therapeutics is an immuno-oncology company focused on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis® technology platform. Argos is developing an Arcelis®-based product candidate, AGS-004, for the treatment of human immunodeficiency virus (HIV), which is currently being evaluated in an investigator-initiated Phase 2 clinical trial aimed at HIV eradication in adult patients. Funding for the development of AGS-004 has been provided by the National Institutes of Health, the National Institute of Allergy and Infectious Diseases, and the Collaboratory of Research for AIDS Eradication.
Your Recent History
FX
EURAUD
Euro vs Au..
FX
USDAUD
US Dollar ..
ASX
WPL
Woodside
NASDAQ
AAPL
Apple
ASX
BHP
BHP Bilito..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20180717 17:00:59